FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/09/021029 [Registered on: 02/09/2019] Trial Registered Prospectively
Last Modified On: 28/08/2019
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Usefulness of Vitamin D Supplements and its Receptor Genetic variations in sugar patients with Infection of Foot from Southern part of India 
Scientific Title of Study   Effect of Vitamin D Supplementation and Vitamin D Receptor Gene Polymorphisms in South-Indian Patients with Diabetic Foot Infection  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shilia Jacob Kurian 
Designation  Ph.D. research scholar 
Affiliation  Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences 
Address  Department of Pharmacy Practice room no 13 kasturba hospital manipal udupi
Manipal Academy of Higher Education, Manipal, Udupi- 576104
Udupi
KARNATAKA
576104
India 
Phone  9886078058  
Fax    
Email  shilia.kurian@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sonal Sekhar M 
Designation  Assistant Professor (Selection Grade) 
Affiliation  Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences 
Address  Department of Pharmacy Practice room no 3 kasturba hospital manipal udupi
Manipal Academy of Higher Education, Manipal, Udupi-576104
Udupi
KARNATAKA
576104
India 
Phone  7411338846  
Fax    
Email  sonal.sekhar@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Shilia Jacob Kurian 
Designation  Ph.D. research scholar 
Affiliation  Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences 
Address  Department of Pharmacy Practice room no 13 kasturba hospital manipal udupi
Manipal Academy of Higher Education, Manipal, Udupi-576104
Udupi
KARNATAKA
576104
India 
Phone  9886078058  
Fax    
Email  shilia.kurian@learner.manipal.edu  
 
Source of Monetary or Material Support  
Kasturba Medical College and hospital, Manipal Academy of Higher education Manipal, Udupi, Karnataka-576104 
 
Primary Sponsor  
Name  Manipal Center for Infectious Diseases 
Address  Manipal Center for Infectious Diseases room no 5 faculty rooms near KMC administrative office manipal 576104 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Shilia Jacob Kurian  Kasturba hospital  Room no: 13, Department of Pharmacy Practice, Kasturba Hospital, Manipal Academy of Higher Education, Madhav nagar manipal Udupi 576104
Udupi
KARNATAKA 
09886078058

shilia.kurian@learner.manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
kasturba medical college and kasturba hospital institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  healthy participants without a previous history of diabetes 
Patients  (1) ICD-10 Condition: E106||Type 1 diabetes mellitus with other specified complications, (2) ICD-10 Condition: E116||Type 2 diabetes mellitus with other specified complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  85.00 Year(s)
Gender  Both 
Details  1. Both genders
2. Age 18 years or older
3. Patients with type 1 or 2 DM
4. Newly diagnosed foot ulcers
5. IDSA: uninfected. (For DFU patients)
6. IDSA: mild/moderate (For DFI patients)
7. Volunteers without a previous history of DM who has come for regular health check-up or blood donation (healthy controls)
8. Participants willing to give the informed consent form and participate in the study
 
 
ExclusionCriteria 
Details  1. Individuals with hepatic disease, renal disease, or other comorbidities that can alter vitamin D levels
2. Diagnosis of lower limb critical ischemia by Doppler ultrasound and ankle/arm index less than 0.5
3. Patients with lower limb ulcers with distal necrosis
4. Patients having clinical evidence of vascular insufficiency
5. Patients currently on steroid (use in the past 30 days) cytotoxic drugs, immunosuppressants, Calcium supplements, multivitamins, and drugs that could alter vitamin D status
6. Pregnant or breastfeeding women
 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Clinical Wound Healing
Health Related Quality of Life (HRQoL) 
4 months 
 
Secondary Outcome  
Outcome  TimePoints 
Quality of life  4 months 
 
Target Sample Size   Total Sample Size="476"
Sample Size from India="476" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/09/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

A prospective cohort study will be conducted to investigate the role of vitamin D in patients with diabetic foot infection (DFI) among South-Indian population. To study the association between vitamin D status and development of foot infection in DFU patients, 80 patients with diabetic foot ulcers (DFU) will be followed up for 4 months to observe the outcome. And to determine the effect of Vitamin D supplementation in clinical and biochemical outcomes; and Quality of life (QoL) among DFI patients, 196 DFI patients will be followed for 4 months. They will be categorized into reference group (RG) and study group (SG). RG patients will not be on vitamin D supplements and SG patients will receive vitamin D supplements. A cross-sectional study will be conducted among 50 subjects each from 4 groups [DFI, DFU (without infection), diabetes patients (without ulcer) and healthy controls] to elucidate VDR gene polymorphisms. The four VDR SNPs: BsmI (SNP ID: rs1544410), ApaI (SNP ID: rs7975232), TaqI (SNP ID: rs731236) and FokI (SNP ID: rs2228570) will be genotyped using TaqMan SNP genotyping assay by a real-time polymerase chain reaction (PCR).

 
Close